e-learning
resources
Paris 2018
Monday, 17.09.2018
Lung cancer: from the bench to the bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alteration patterns of tobacco carcinogens in lung adenocarcinoma reveal novel KRAS-addicted candidate oncogenes
M. Pepe (Munich, Germany), F. Pelizza (Glascow, United Kingdom), A. Lamort (Munich, Germany), N. Kanellakis (Patras, Greece), G. Stathopoulos (Munich, Germany)
Source:
International Congress 2018 – Lung cancer: from the bench to the bedside
Session:
Lung cancer: from the bench to the bedside
Session type:
Thematic Poster
Number:
2841
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Pepe (Munich, Germany), F. Pelizza (Glascow, United Kingdom), A. Lamort (Munich, Germany), N. Kanellakis (Patras, Greece), G. Stathopoulos (Munich, Germany). Alteration patterns of tobacco carcinogens in lung adenocarcinoma reveal novel KRAS-addicted candidate oncogenes. 2841
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: ERS Lung Science Conference 2017
Year: 2017
Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
LSC - 2020 - Transcriptome signatures of tobacco carcinogens hint the alteration of TAF6 as a specific feature in smokers lung cancer
Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases
Year: 2020
Influence of smoking on gene expression in lung adenocarcinoma
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Evolution of microRNA expression during human bronchial squamous carcinogenesis
Source: Eur Respir J 2009; 33: 352-359
Year: 2009
Identifying a tissue specific microRNA molecular signature in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
Identification of differentially expressed genes in squamous cell carcinoma of the lung using differential display
Source: Eur Respir J 2005; 26: Suppl. 49, 457s
Year: 2005
Identification of membrane-associated proteins as new candidate biomarkers of small-cell lung cancer
Source: Annual Congress 2010 - The role of biomarkers in lung cancer
Year: 2010
Differential expression analysis of lncRNA in different types of lung cancer
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Early lung carcinogenesis: MDM2 expression in bronchial preneoplastic lesions and its correlation with p53
Source: Eur Respir J 2005; 26: Suppl. 49, 458s
Year: 2005
PP135 – Mutational RNA signatures in environmentally-induced lung adenocarcinoma
Source: ERS Lung Science Conference 2021
Year: 2021
Mutational RNA signatures in environmentally-induced lung adenocarcinoma
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
Biomarkers of lung cancer based on the expression of genes, transposons and repetitive elements
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Cancer-associated oncogenic BARD1 isoforms: From biomarker expression studies to development of a blood test for early detection of lung cancer
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012
Mapping of Kras mutations during chemical carcinogenesis
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
PP134 – Mapping of Kras mutations during chemical carcinogenesis
Source: ERS Lung Science Conference 2021
Year: 2021
Epigenetic inactivation of
checkpoint kinase 2
gene in nonsmall cell lung cancer and its relationship with clinicopathological features
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
Tumoural tissue specific promoter hypermethylation of distinct tumour suppressor genes in a case with nonsmall cell lung carcinoma: a case report
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept